Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the launch of its next-generation RhinAer(R) device as well as UnitedHealthcare's Medicare ...
Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of long-term results from a multicenter study evaluating the safety and ...
The Food and Drug Administration (FDA) has cleared Neuromark™ Rhinitis Neurolysis Therapy™ for otorhinolaryngology surgery for creation of radiofrequency lesions to disrupt posterior nasal nerves in ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions ...
Please provide your email address to receive an email when new articles are posted on . 45.2% of patients who had “nasal allergies” had chronic rhinosinusitis. Patients with CRS tended to be older ...
Please provide your email address to receive an email when new articles are posted on . The RhinAer system generates and applies 4 W of 60°C temperature-controlled bipolar radiofrequency energy to the ...
— G.W.T.Dear G.W.T.: The sinus of the heart has nothing to do with your nose as you might guess; it's a structure in the ...
Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of long-term results from a multicenter study evaluating the safety and ...
MOUNTAIN VIEW, Calif., October 23, 2025--(BUSINESS WIRE)--Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the launch of its next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback